Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share Price

Price 15,344.00p on 23-02-2026 at 16:58:59
Change 74.00p 0.48%
Buy 15,348.00p
Sell 15,344.00p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Sell 684.00 at 15,344.00p
Day's Volume: 1,808,448
Last Close: 15,344.00p
Open: 15,188.00p
ISIN: GB0009895292
Day's Range 15,080.00p - 15,356.00p
52wk Range: 9,574.00p - 15,730.00p
Market Capitalisation: £237.88b
VWAP: 15,248.23216p
Shares in Issue: 1.55b

Sector: Medicine and Biotech

Listed In: FTSE All-Share, FTSE All-Share ex Investment Trusts, FTSE Lower Yield, FTSE 350 ex Investment Trusts, FTSE 350 , FTSE 100,

Astrazeneca (AZN) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 684 15,344.00p SI Trade
Suspected SELL Trade
 16:58:58 - 23-Feb-26
Sell* 128 15,344.00p SI Trade
Suspected SELL Trade
 16:58:58 - 23-Feb-26
Unknown* 0 15,278.25355p Currency Conversion
OTC Trade
 16:56:38 - 23-Feb-26
Sell* 159 15,344.00p SI Trade
Suspected SELL Trade
 16:49:35 - 23-Feb-26
Sell* 6,235 15,208.852p SI Trade
Suspected SELL Trade
 16:47:06 - 23-Feb-26
Unknown* 0 15,288.61169p SI Trade
Currency Conversion
 16:44:08 - 23-Feb-26
Unknown* 0 15,293.79076p SI Trade
Currency Conversion
 16:40:49 - 23-Feb-26
Unknown* 0 15,264.93594p SI Trade
Currency Conversion
 16:39:36 - 23-Feb-26
Buy* 711 15,344.00p Automatic Execution
 16:37:57 - 23-Feb-26
Buy* 600 15,344.00p Automatic Execution
 16:37:57 - 23-Feb-26
See more Astrazeneca trades

Astrazeneca (AZN) Share Price History

Time period:
to
Date Open High Low Close Volume
23rd Feb 2026 (Mon) 15,188.00 15,356.00 15,080.00 15,344.00 1,808,448
20th Feb 2026 (Fri) 15,422.00 15,424.00 15,224.00 15,270.00 7,485,202
19th Feb 2026 (Thu) 15,390.00 15,426.00 15,162.00 15,290.00 1,991,093
18th Feb 2026 (Wed) 15,498.00 15,730.00 15,484.00 15,542.00 1,448,505
17th Feb 2026 (Tue) 15,174.00 15,522.00 15,174.00 15,522.00 2,510,009
16th Feb 2026 (Mon) 15,186.00 15,188.00 14,944.00 15,160.00 2,085,798
13th Feb 2026 (Fri) 14,986.00 15,186.00 14,816.00 15,118.00 6,247,443
12th Feb 2026 (Thu) 14,918.00 15,028.00 14,782.00 14,906.00 1,393,202
11th Feb 2026 (Wed) 14,118.00 14,818.00 14,074.00 14,818.00 3,601,531
10th Feb 2026 (Tue) 13,952.00 14,314.00 13,748.00 14,164.00 3,682,197
9th Feb 2026 (Mon) 14,184.00 14,250.00 13,858.00 13,888.00 4,085,396
6th Feb 2026 (Fri) 13,884.00 14,112.00 13,846.00 14,104.00 3,108,416
5th Feb 2026 (Thu) 13,790.00 14,068.00 13,696.00 13,980.00 1,437,883
4th Feb 2026 (Wed) 13,472.00 13,926.00 13,444.00 13,796.00 2,067,316
3rd Feb 2026 (Tue) 13,808.00 13,942.00 13,636.00 13,816.00 1,443,630
2nd Feb 2026 (Mon) 13,532.00 14,060.00 13,500.00 14,040.00 1,342,224
30th Jan 2026 (Fri) 13,328.00 13,600.00 13,326.00 13,600.00 1,640,379
29th Jan 2026 (Thu) 13,406.00 13,564.00 13,402.00 13,460.00 2,707,843
28th Jan 2026 (Wed) 13,818.00 13,822.00 13,478.00 13,508.00 2,526,744
27th Jan 2026 (Tue) 13,800.00 13,986.00 13,736.00 13,880.00 1,444,248
26th Jan 2026 (Mon) 13,642.00 13,770.00 13,560.00 13,752.00 1,555,763
23rd Jan 2026 (Fri) 13,702.00 13,704.00 13,512.00 13,580.00 1,574,503
See more Astrazeneca price history

Astrazeneca (AZN) Regulatory News

Date Source Headline
20th Feb 2026 7:00 am RNS Fixed-duration Calquence combo approved in US
10th Feb 2026 7:00 am RNS Final Results
3rd Feb 2026 7:00 am RNS Update on Saphnelo subcutaneous administration
2nd Feb 2026 3:00 pm RNS Total Voting Rights
2nd Feb 2026 7:05 am RNS Imfinzi recommended in EU for early gastric cancer
2nd Feb 2026 7:00 am RNS AstraZeneca begins trading on NYSE
30th Jan 2026 7:00 am RNS AstraZeneca agrees obesity and T2D deal with CSPC
29th Jan 2026 9:51 am RNS AstraZeneca invests $15bn in China through 2030
20th Jan 2026 7:00 am RNS AstraZeneca to complete direct listing on NYSE
8th Jan 2026 7:00 am RNS AZN new Head of Investor Relations Joris Silon
See more Astrazeneca regulatory news

Astrazeneca (AZN) Share News

LONDON MARKET OPEN: Stocks fall after latest tariff salvo

23rd Feb 2026 08:51

(Alliance News) - Stock prices in Europe moved lower in early dealings on Monday, with enthusiasm at the start of the week tempered by tariff uncertainty, as US President Donald Trump hit out at a Supreme Court ruling and announced new trade curbs. Read More

US regulator FDA greenlights AbbVie and AstraZeneca's cancer treatment

20th Feb 2026 10:45

(Alliance News) - AbbVie Inc and AstraZeneca PLC on Friday hailed a regulatory win for their joint cancer treatment programme. Read More

LONDON BROKER RATINGS: Three brokers cut Unilever to 'hold' from 'buy'

18th Feb 2026 09:30

(Alliance News) - The following London-listed shares received analyst recommendations on Wednesday morning and on Tuesday: Read More

LONDON BROKER RATINGS: RBC cuts Schroders, LBBW says 'hold' Unilever

16th Feb 2026 09:53

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More

LONDON MARKET MIDDAY: Stocks edge lower ahead of US CPI data

13th Feb 2026 12:12

(Alliance News) - Stock prices in London were modestly lower at midday on Friday, with sentiment cautious ahead of US inflation data and the Munich Security Conference in focus. Read More

See more Astrazeneca news
FTSE 100 Latest
Value10,684.74
Change-2.15

Login to your account

Forgot Password?

Not Registered